Global law firm Norton Rose Fulbright announced today that leading corporate M&A and private equity partner Bryan Pointon will join the firm in Sydney on October 1.
Bryan is a senior practitioner with a wealth of experience in the health; technology, media and telecommunications; food and beverage; and agribusiness sectors. Across his diverse career he has advised on public law litigation, US securities (having previously been admitted to practise in New York), telecommunications and media, corporate M&A and private equity matters. He has also advised on complex government transactions and privatisations.
Bryan has strong relationships with investment banking clients active in M&A, private equity and equity capital markets, along with a significant number of major international and domestic public companies across a range of other industries.
He was most recently a partner in PwC Legal’s financial advisory practice. Prior to that, he was Asia-Pacific head of corporate at DLA Piper, and a senior corporate M&A partner at Gilbert+Tobin and King & Wood Mallesons.
Norton Rose Fulbright managing partner in Australia, Alison Deitz, commented:
“Bryan’s stellar reputation precedes him. His career has been marked by a series of influential roles that helped strengthen client relationships and win significant new matters in Australia and the broader Asia-Pacific region, and his leadership qualities and experience will add significant capability and depth to our corporate M&A practice. We are delighted that our clients will be able to benefit from the breadth of Bryan’s experience advising on some of the most noteworthy corporate M&A, private equity and government transactions in the market.”
Bryan Pointon commented:
“Australia, along with the rest of the world, is about to embark on a difficult period of rising distressed M&A activity that will eventually give way to the kind of deal-making that comes with economic revival and growth. Over that time, clients will need trusted advisors that can bring a combination of domestic scale and genuinely global reach, capability and insight. Norton Rose Fulbright has all of those ingredients and is perfectly placed to assist companies and governments to manage risk and pursue new opportunities flowing from the COVID-19 pandemic.”